ICUI ICU Medical Inc.

ICU Medical, Inc. to Participate in Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum

ICU Medical, Inc. to Participate in Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum

SAN CLEMENTE, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 7:45 a.m. PT (10:45 a.m. ET) on Tuesday, March 23, 2021.

The fireside chat will be webcast live and can be accessed by going to the Company’s website at , clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.

About ICU Medical, Inc.

ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at .

CONTACT:

ICU Medical, Inc.

Brian Bonnell, Chief Financial Officer

(949) 366-2183

ICR, Inc.

John Mills, Managing Partner

(646) 277-1254

Source: ICU Medical, Inc.



EN
18/03/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ICU Medical Inc.

 PRESS RELEASE

ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor...

ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024. ICU Medical’s presentation will be on Wednesday, March 20, 2024 at 11:15 a.m. PT (2:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, March 20, 2024. The pr...

 PRESS RELEASE

ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional ...

ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024. ICU Medical’s presentation will be on Monday, March 4, 2024 at 4:30 a.m. PT (7:30 a.m. ET). Company management will also be participating in one-on-one meetings o...

 PRESS RELEASE

ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal ...

ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance SAN CLEMENTE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2023. Fourth Quarter 2023 Results Fourth quarter 2023 revenue was $587.9 million, compared to $578.0 million in the same period in the prior year. GAAP gross profit for the fourth quarter of 2023 was $171.6 million, as compared to $174.9 million in the...

 PRESS RELEASE

ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference ...

ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference Call SAN CLEMENTE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2023 earnings release and conference call. The Company will release its fourth quarter 2023 results on Tuesday, February 27th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Tuesday, February 27t...

ICU Medical, Inc.: Slow deleveraging reflecting ongoing challenges to ...

Our credit view of this issuer reflects its attractive margins and its good size and scale, offset by its high financial leverage and elevated regulatory risk.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch